Increased adiposity has been associated with adipose tissue low-grade
inflammation leading to
insulin resistance. Adipocyte differentiation inhibitors are expected to be effective in preventing
obesity and related diseases.
Anthocyanins (ACNs) are associated to enhanced adipocyte function and protection from metabolic stress. Herein, we evaluated the in vitro protective effects of an
ACN rich extract against
palmitic acid (PA)-induced
hypertrophy,
inflammation, and
insulin resistance in 3T3-L1 adipocytes.
ACN extract pretreatment reduces
lipid accumulation and
peroxisome proliferators-activated receptor-γ
protein levels induced by PA. In addition, PA induces
inflammation with activation of NF-κB pathway, whereas
ACN extract pretreatment dose-dependently inhibited this pathway. Furthermore, adipocyte dysfunction associated with
hypertrophy induces
insulin resistance by affecting
phosphatidylinositol 3-kinase-protein
kinase B/Akt axis, GLUT-1, and
adiponectin mRNA levels.
ACN extract pretreatment reverts these effects induced by PA and moreover was able to induce
insulin pathway with levels higher than
insulin control cells, supporting an
insulin sensitizer role for ACNs. This study demonstrates a prevention potential of ACNs against
obesity comorbidities, due to their protective effects against
inflammation/
insulin resistance in adipocytes. In addition, these results contribute to the knowledge and strategies on the evaluation of the mechanism of action of ACNs from a food source under basal and
insulin resistance conditions related to
obesity.